Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (8321)	5/9/2003 2:18:36 PM
From: jayhawk969	Respond to of 52153

After SEPR and NTII I am a believer. Not too confident in shorting NBIX however.

To: Biomaven who wrote (8321)	5/9/2003 3:47:42 PM
From: OldAIMGuy	Respond to of 52153

Hi Peter, Thanks for the reply. Although the short positions on several of my biotechs have not changed as much as the IBB surrogate, the trend of the fund may soon come to be reflected in my obscure bios. I'm now using SI's graphing ability to look at my various holdings against the backdrop of IBB. It helps me to discern between "sector" events and "company" events. siliconinvestor.com Best regards, Tom